{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:04:41Z","timestamp":1791212681333,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1038\/nm.4500","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T16:03:38Z","timestamp":1520265818000},"page":"427-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy"],"prefix":"10.1038","volume":"24","author":[{"given":"Nisha M","family":"Badders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Korff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep K","family":"Vuppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett J","family":"Winborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle R","family":"Quemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce L","family":"Sopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D","family":"Freibaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson P","family":"Kanagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-2812","authenticated-orcid":false,"given":"Heather","family":"Tillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burgess B.","family":"Freeman III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R","family":"La Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"BFnm4500_CR1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy, W.R., Alter, M. & Sung, J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671\u2013680 (1968).","journal-title":"Neurology"},{"key":"BFnm4500_CR2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000312510.49768.eb","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin, N., Klein, C., Mandrekar, J. & Sorenson, E. Natural history of spinal-bulbar muscular atrophy. Neurology 70, 1967\u20131971 (2008).","journal-title":"Neurology"},{"key":"BFnm4500_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/ENDO:28:3:243","volume":"28","author":"A Poletti","year":"2005","unstructured":"Poletti, A., Negri-Cesi, P. & Martini, L. Reflections on the diseases linked to mutations of the androgen receptor. Endocrine 28, 243\u2013262 (2005).","journal-title":"Endocrine"},{"key":"BFnm4500_CR4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/WNL.0000000000000507","volume":"82","author":"P Fratta","year":"2014","unstructured":"Fratta, P. et al. Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology 82, 2077\u20132084 (2014).","journal-title":"Neurology"},{"key":"BFnm4500_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm4500_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","volume":"264","author":"G Sorar\u00f9","year":"2008","unstructured":"Sorar\u00f9, G. et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264, 100\u2013105 (2008).","journal-title":"J. Neurol. Sci."},{"key":"BFnm4500_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.08.025","volume":"298","author":"J Finsterer","year":"2010","unstructured":"Finsterer, J. Perspectives of Kennedy's disease. J. Neurol. Sci. 298, 1\u201310 (2010).","journal-title":"J. Neurol. Sci."},{"key":"BFnm4500_CR8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky, N.B. et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67, 936\u2013952 (2010).","journal-title":"Neuron"},{"key":"BFnm4500_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","volume":"25","author":"CL Smith","year":"2004","unstructured":"Smith, C.L. & O'Malley, B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25, 45\u201371 (2004).","journal-title":"Endocr. Rev."},{"key":"BFnm4500_CR10","doi-asserted-by":"crossref","first-page":"25801","DOI":"10.1074\/jbc.M703268200","volume":"282","author":"EB Askew","year":"2007","unstructured":"Askew, E.B., Gampe, R.T. Jr., Stanley, T.B., Faggart, J.L. & Wilson, E.M. Modulation of androgen receptor activation function 2 2 by testosterone and dihydrotestosterone. J. Biol. Chem. 282, 25801\u201325816 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm4500_CR11","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen, E.S. et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24, 4778\u20134786 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm4500_CR12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"BFnm4500_CR13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768\u2013773 (2003).","journal-title":"Nat. Med."},{"key":"BFnm4500_CR14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno, M. et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 9, 875\u2013884 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnm4500_CR15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1547","volume":"13","author":"Z Yang","year":"2007","unstructured":"Yang, Z. et al. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 13, 348\u2013353 (2007).","journal-title":"Nat. Med."},{"key":"BFnm4500_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno, H. et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann. Neurol. 65, 140\u2013150 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnm4500_CR17","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1021\/jm200532b","volume":"54","author":"P Axerio-Cilies","year":"2011","unstructured":"Axerio-Cilies, P. et al. Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening. J. Med. Chem. 54, 6197\u20136205 (2011).","journal-title":"J. Med. Chem."},{"key":"BFnm4500_CR18","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1021\/jm500684r","volume":"57","author":"F Ban","year":"2014","unstructured":"Ban, F. et al. Discovery of 1H-indole-2-carboxamides as novel inhibitors of the androgen receptor binding function 3 3 (BF3). J. Med. Chem. 57, 6867\u20136872 (2014).","journal-title":"J. Med. Chem."},{"key":"BFnm4500_CR19","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1073\/pnas.0708036104","volume":"104","author":"E Est\u00e9banez-Perpi\u00f1\u00e1","year":"2007","unstructured":"Est\u00e9banez-Perpi\u00f1\u00e1, E. et al. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc. Natl. Acad. Sci. USA 104, 16074\u201316079 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4500_CR20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1021\/jm3015712","volume":"56","author":"RS Munuganti","year":"2013","unstructured":"Munuganti, R.S. et al. Targeting the binding function 3 3 (BF3) site of the androgen receptor through virtual screening. 2. development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole derivatives. J. Med. Chem. 56, 1136\u20131148 (2013).","journal-title":"J. Med. Chem."},{"key":"BFnm4500_CR21","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/jm201098n","volume":"54","author":"NA Lack","year":"2011","unstructured":"Lack, N.A. et al. Targeting the binding function 3 3 (BF3) site of the human androgen receptor through virtual screening. J. Med. Chem. 54, 8563\u20138573 (2011).","journal-title":"J. Med. Chem."},{"key":"BFnm4500_CR22","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.chembiol.2014.09.012","volume":"21","author":"RS Munuganti","year":"2014","unstructured":"Munuganti, R.S. et al. Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer. Chem. Biol. 21, 1476\u20131485 (2014).","journal-title":"Chem. Biol."},{"key":"BFnm4500_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00401-016-1550-4","volume":"132","author":"A Rocchi","year":"2016","unstructured":"Rocchi, A. et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 132, 127\u2013144 (2016).","journal-title":"Acta Neuropathol."},{"key":"BFnm4500_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410210512","volume":"21","author":"NR Cashman","year":"1987","unstructured":"Cashman, N.R., Covault, J., Wollman, R.L. & Sanes, J.R. Neural cell adhesion molecule in normal, denervated, and myopathic human muscle. Ann. Neurol. 21, 481\u2013489 (1987).","journal-title":"Ann. Neurol."},{"key":"BFnm4500_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jemt.1170","volume":"55","author":"G Gosztonyi","year":"2001","unstructured":"Gosztonyi, G., Naschold, U., Grozdanovic, Z., Stoltenburg-Didinger, G. & Gossrau, R. Expression of Leu-19 (CD56, N-CAM) and nitric oxide synthase (NOS) I in denervated and reinnervated human skeletal muscle. Microsc. Res. Tech. 55, 187\u2013197 (2001).","journal-title":"Microsc. Res. Tech."},{"key":"BFnm4500_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0387-7604(01)00394-1","volume":"24","author":"A Marbini","year":"2002","unstructured":"Marbini, A. et al. Immunohistochemical study of muscle biopsy in children with cerebral palsy. Brain Dev. 24, 63\u201366 (2002).","journal-title":"Brain Dev."},{"key":"BFnm4500_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2006.050619","volume":"168","author":"Z Yu","year":"2006","unstructured":"Yu, Z. et al. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am. J. Pathol. 168, 195\u2013204 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnm4500_CR28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3892\/ijmm.2013.1474","volume":"32","author":"JH Sun","year":"2013","unstructured":"Sun, J.H. & Lee, S.A. Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms. Int. J. Mol. Med. 32, 1195\u20131203 (2013).","journal-title":"Int. J. Mol. Med."},{"key":"BFnm4500_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/hmg\/ddm287","volume":"17","author":"MA Albertelli","year":"2008","unstructured":"Albertelli, M.A. et al. Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice. Hum. Mol. Genet. 17, 98\u2013110 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4500_CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2007.09.002","volume":"108","author":"DM Robins","year":"2008","unstructured":"Robins, D.M., Albertelli, M.A. & O'Mahony, O.A. Androgen receptor variants and prostate cancer in humanized AR mice. J. Steroid Biochem. Mol. Biol. 108, 230\u2013236 (2008).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"BFnm4500_CR31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/hmg\/ddh181","volume":"13","author":"G Buchanan","year":"2004","unstructured":"Buchanan, G. et al. Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum. Mol. Genet. 13, 1677\u20131692 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4500_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2011.05.023","volume":"342","author":"G Buchanan","year":"2011","unstructured":"Buchanan, G. et al. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor\/corepressor ratio in prostate cancer cells. Mol. Cell. Endocrinol. 342, 20\u201331 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnm4500_CR33","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1074\/jbc.M113.534859","volume":"289","author":"K Jehle","year":"2014","unstructured":"Jehle, K. et al. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. J. Biol. Chem. 289, 8839\u20138851 (2014).","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 2","key":"BFnm4500_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0773.1994.tb01991.x","volume":"75","author":"T Corell","year":"1994","unstructured":"Corell, T. Pharmacology of tolfenamic acid. Pharmacol. Toxicol. 75 (Suppl. 2), 14\u201321 (1994).","journal-title":"Pharmacol. Toxicol."},{"issue":"Suppl. 2","key":"BFnm4500_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0773.1994.tb01998.x","volume":"75","author":"J Hendel","year":"1994","unstructured":"Hendel, J. The overall safety of tolfenamic acid. Pharmacol. Toxicol. 75 (Suppl. 2), 53\u201355 (1994).","journal-title":"Pharmacol. Toxicol."},{"issue":"Suppl. 2","key":"BFnm4500_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0773.1994.tb01996.x","volume":"75","author":"L Hendel","year":"1994","unstructured":"Hendel, L., Larsen, E. & Bonnevie, O. A comparative study of the influence of tolfenamic acid (Clotam) and diclofenac sodium (Voltaren) on the gastrointestinal mucosa in patients with a history of NSAID-related dyspeptic symptoms. Pharmacol. Toxicol. 75 (Suppl. 2), 49\u201350 (1994).","journal-title":"Pharmacol. Toxicol."},{"issue":"Suppl. 2","key":"BFnm4500_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0773.1994.tb01992.x","volume":"75","author":"SB Pedersen","year":"1994","unstructured":"Pedersen, S.B. Biopharmaceutical aspects of tolfenamic acid. Pharmacol. Toxicol. 75 (Suppl. 2), 22\u201332 (1994).","journal-title":"Pharmacol. Toxicol."},{"key":"BFnm4500_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11010-010-0388-7","volume":"339","author":"H Yuan","year":"2010","unstructured":"Yuan, H. et al. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol. Cell. Biochem. 339, 253\u2013262 (2010).","journal-title":"Mol. Cell. Biochem."},{"key":"BFnm4500_CR39","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1158\/1535-7163.MCT-08-0461","volume":"7","author":"MC Hodgson","year":"2008","unstructured":"Hodgson, M.C., Shen, H.C., Hollenberg, A.N. & Balk, S.P. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor. Mol. Cancer Ther. 7, 3187\u20133194 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"BFnm4500_CR40","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddw073","volume":"25","author":"LC Bott","year":"2016","unstructured":"Bott, L.C. et al. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 25, 1979\u20131989 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4500_CR41","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/hmg\/ddi326","volume":"14","author":"MW Glynn","year":"2005","unstructured":"Glynn, M.W. & Glover, T.W. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum. Mol. Genet. 14, 2959\u20132969 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4500_CR42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"BFnm4500_CR43","unstructured":"D'Argenio, D.Z., Schumitzky, A. & Wang, X. ADAPT 5 User's Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software (Los Angeles: Biomedical Simulations Resource, 2009)."},{"key":"BFnm4500_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal, S.L. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 28, 481\u2013504 (2001).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"BFnm4500_CR45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","volume":"13","author":"RP Brown","year":"1997","unstructured":"Brown, R.P., Delp, M.D., Lindstedt, S.L., Rhomberg, L.R. & Beliles, R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13, 407\u2013484 (1997).","journal-title":"Toxicol. Ind. Health"},{"key":"BFnm4500_CR46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/toxsci\/kfn064","volume":"104","author":"ML Gargas","year":"2008","unstructured":"Gargas, M.L. et al. Physiologically based pharmacokinetic modeling of chloroethane disposition in mice, rats, and women. Toxicol. Sci. 104, 54\u201366 (2008).","journal-title":"Toxicol. Sci."},{"key":"BFnm4500_CR47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3181\/00379727-75-18083","volume":"75","author":"N Kaliss","year":"1950","unstructured":"Kaliss, N. & Pressman, D. Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins. Proc. Soc. Exp. Biol. Med. 75, 16\u201320 (1950).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFnm4500_CR48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2202-5-6","volume":"5","author":"DL McIlwain","year":"2004","unstructured":"McIlwain, D.L., Hoke, V.B., Kopchick, J.J., Fuller, C.R. & Lund, P.K. Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist. BMC Neurosci. 5, 6 (2004).","journal-title":"BMC Neurosci."},{"key":"BFnm4500_CR49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mrm.21567","volume":"59","author":"G Duhamel","year":"2008","unstructured":"Duhamel, G., Callot, V., Cozzone, P.J. & Kober, F. Spinal cord blood flow measurement by arterial spin labeling. Magn. Reson. Med. 59, 846\u2013854 (2008).","journal-title":"Magn. Reson. Med."},{"key":"BFnm4500_CR50","doi-asserted-by":"crossref","unstructured":"Gibaldi, M. & Perrier, D. Pharmacokinetics 2nd edn (CRC Press, 1982).","DOI":"10.1201\/b14095"},{"key":"BFnm4500_CR51","first-page":"S65","volume":"42","author":"W Denney","year":"2015","unstructured":"Denney, W., Duvvuri, S. & Buckeridge, C. Simple, automatic noncompartmental analysis: the PKNCA R package. J. Pharmacokinet. Pharmacodyn. 42, S65 (2015).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"BFnm4500_CR52","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2016)."},{"key":"BFnm4500_CR53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/nbdi.1997.0126","volume":"3","author":"BP Brooks","year":"1997","unstructured":"Brooks, B.P. et al. Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol. Dis. 3, 313\u2013323 (1997).","journal-title":"Neurobiol. Dis."}],"updated-by":[{"DOI":"10.1038\/s41591-023-02778-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.4500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.4500","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nm.4500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nm.4500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:28:51Z","timestamp":1739356131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"alternative-id":["BFnm4500"],"URL":"https:\/\/doi.org\/10.1038\/nm.4500","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41591-023-02778-7","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"25 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-023-02778-7","URL":"https:\/\/doi.org\/10.1038\/s41591-023-02778-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}